Critical role of insulin‑like growth factor binding protein‑5 in methamphetamine‑induced apoptosis in cardiomyocytes

Ka-Pui Leung1, Yi-Hong Qu1, Dong-Fang Qiao1

  • 1Department of Forensic Medicine, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China.

Molecular Medicine Reports
|September 19, 2014
PubMed

Insights

This study reveals that Insulin-like growth factor binding protein-5 (IGFBP5) plays a key role in methamphetamine-induced cardiotoxicity. Inhibiting IGFBP5 significantly reduced heart cell death, suggesting it as a potential therapeutic target.

Area of Science:

  • Cardiology
  • Toxicology
  • Molecular Biology

Background:

  • Methamphetamine (MA) abuse causes cardiotoxicity, but the underlying mechanisms, particularly apoptosis, remain unclear.
  • Insulin-like growth factor binding protein-5 (IGFBP5) is implicated in cell growth and apoptosis.
  • Understanding MA's impact on cardiac cells is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the role of IGFBP5 in methamphetamine-induced cardiotoxicity.
  • To determine if IGFBP5 is a potential therapeutic target for MA-induced heart damage.
  • To elucidate the specific apoptotic pathways involved.

Main Methods:

  • Neonatal rat ventricular myocytes (NRVMs) were treated with varying concentrations of MA.
  • Apoptosis was assessed using the terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay.
  • IGFBP5 expression was analyzed via reverse transcription polymerase chain reaction (RT-PCR) and Western blotting.
  • IGFBP5 was silenced using small interfering RNA (siRNA) to evaluate its effect on MA-induced apoptosis and caspase-3 expression.

Main Results:

  • Methamphetamine induced apoptosis in NRVMs in a concentration-dependent manner.
  • MA treatment led to increased expression of IGFBP5 in a concentration-dependent manner.
  • Silencing IGFBP5 significantly reduced MA-induced apoptosis and suppressed caspase-3 expression.
  • These findings suggest IGFBP5 is a mediator of MA cardiotoxicity.

Conclusions:

  • This study provides the first evidence that IGFBP5 is involved in methamphetamine-induced apoptosis in vitro.
  • IGFBP5 emerges as a potential therapeutic target for mitigating MA-induced cardiotoxicity.
  • Further in vivo studies are warranted to validate these findings and explore therapeutic strategies.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.1K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.1K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
57
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
11.9K